when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Obesity · news · pharmadog

← back to Obesity

News mentioning Obesity

367 stories

Jun 8, 26STAT+: J&J spends $1 billion to enter KRAS race for cancer treatmentsstat

Jun 8, 26Major readouts from the annual diabetes conferencestat

Jun 8, 26STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response ratestat

Jun 8, 26Opinion: American horses are obese, toostat

Jun 8, 26Opinion: $2 million gene therapy cures require a financing modelstat

Jun 7, 26STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADAstat

Jun 7, 26#ADA26: 19% of Phase 3 patients quit Boehringer obesity shot over side effectsendpoints

Jun 7, 26STAT+: New data may cast doubt on competitiveness of Boehringer’s obesity drugstat

Jun 6, 26STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet endingstat

Jun 6, 26STAT+: Lilly shares safety, tolerability data on its next-gen obesity drugstat

Jun 6, 26#ADA26: Pfizer's monthly shot shows effect on obesity, diabetesendpoints

Jun 6, 26STAT+: Detailed data show Pfizer’s monthly obesity drug continues to show potentialstat

Jun 6, 26#ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this yearendpoints

Jun 5, 26Texas AG investigating energy drinksstat

Jun 4, 26What RevMed’s pancreatic cancer drug meant for one patientstat

Jun 4, 26Novo Holdings backs European fund; Alnylam sends second obesity drug into clinicendpoints

Jun 4, 26Male puberty is understudied — but when it starts may predict long-term health risksstat

Jun 3, 26NewLimit’s $435M megaround; Lilly’s busy dealmaking weekbiopharma dive

Jun 3, 26STAT+: Legend Biotech emerged as a rare market winnerstat

Jun 3, 26Is the military fueling eating disorders?stat

Jun 3, 26Top ultra-processed food researchers call for sweeping policy change: ‘The system is rigged’stat

Jun 3, 26Opinion: The medical-billing AI arms race between providers and insurancestat

Jun 3, 26STAT+: NIH cuts weakened network primed to respond to outbreaks like Ebolastat

Jun 2, 26Eli Lilly issues data sharing ultimatum to 340B hospitalsbiopharma dive

Jun 2, 26STAT+: Radiopharmaceutical shows promise in post-Pluvicto settingstat

Jun 2, 26STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and morestat

Jun 2, 26Obesity care startup Ilant Health raises $15Mendpoints

Jun 1, 26STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discountsstat

Jun 1, 26STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concernsstat

Jun 1, 26STAT+: Medicare’s mum on GLP-1s, and Massachusetts sues Unitedstat

← prevpage 9 of 13next →